4//SEC Filing
Reiss-Clark Cindy 4
Accession 0001562180-23-006564
CIK 0000105770other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 7:24 PM ET
Size
16.1 KB
Accession
0001562180-23-006564
Insider Transaction Report
Form 4
Reiss-Clark Cindy
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-22$369.13/sh+777$286,814→ 7,797.161 total - Exercise/Conversion
Stock Options (Right to buy)
2023-08-22$393.34/sh−777$305,625→ 2,331 totalExercise: $369.13From: 2023-02-22Exp: 2032-02-22→ Common Stock (777 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2023-08-22$393.34/sh−1,112$437,394→ 1,756 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Common Stock (1,112 underlying) - Exercise/Conversion
Common Stock
2023-08-22$173.22/sh+1,112$192,621→ 5,432.161 total - Exercise/Conversion
Stock Options (Right to buy)
2023-08-22$393.34/sh−1,588$624,624→ 1,588 totalExercise: $274.29From: 2022-02-23Exp: 2031-02-23→ Common Stock (1,588 underlying) - Sale
Common Stock
2023-08-22$393.34/sh−3,477$1,367,643→ 4,320.161 total - Exercise/Conversion
Common Stock
2023-08-22$274.29/sh+1,588$435,573→ 7,020.161 total
Footnotes (3)
- [F1]This award vests in four equal annual installments beginning on February 22, 2023.
- [F2]This award vests in four equal annual installments beginning on February 23, 2022.
- [F3]This award vests in four equal annual installments beginning on February 18, 2021.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001916513
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 7:24 PM ET
- Size
- 16.1 KB